title: HIV-1 tat transcriptional activity is regulated by acetylation.
abstract: The human immunodeficiency virus (HIV) trans- activator protein, Tat, stimulates transcription from the viral long-terminal repeats (LTR) through an RNA hairpin element, trans-activation responsive region (TAR). We and others have shown that trans-activator protein (Tat)-associated histone acetyltransferases (TAHs), p300 and p300/CBP-associating factor (PCAF), assist functionally in the activation of chromosomally integrated HIV-1 LTR. Here, we show that p300 and PCAF also directly acetylate Tat. We defined two sites of acetylation located in different functional domains of Tat. p300 acetylated Lys50 in the TAR RNA binding domain, while PCAF acetylated Lys28 in the activation domain of Tat. In support of a functional role for acetylation in vivo, histone deacetylase inhibitor (trichostatin A) synergized with Tat in transcriptional activation of the HIV-1 LTR. Synergism was TAR-dependent and required the intact presence of both Lys28 and Lys50. Mechanistically, acetylation at Lys28 by PCAF enhanced Tat binding to the Tat-associated kinase, CDK9/P-TEFb, while acetylation by p300 at Lys50 of Tat promoted the dissociation of Tat from TAR RNA that occurs during early transcription elongation. These data suggest that acetylation of Tat regulates two discrete and functionally critical steps in transcription, binding to an RNAP II CTD-kinase and release of Tat from TAR RNA.
authors.affiliation: Laboratoire de Virologie Moléculaire et Transfert de Gène, Institut de Génétique Humaine, UPR1142 Montpellier, 34396, France.
authors.forename: R E
authors.initials: RE
authors.lastname: Kiernan
authors.forename: C
authors.initials: C
authors.lastname: Vanhulle
authors.forename: L
authors.initials: L
authors.lastname: Schiltz
authors.forename: E
authors.initials: E
authors.lastname: Adam
authors.forename: H
authors.initials: H
authors.lastname: Xiao
authors.forename: F
authors.initials: F
authors.lastname: Maudoux
authors.forename: C
authors.initials: C
authors.lastname: Calomme
authors.forename: A
authors.initials: A
authors.lastname: Burny
authors.forename: Y
authors.initials: Y
authors.lastname: Nakatani
authors.forename: K T
authors.initials: KT
authors.lastname: Jeang
authors.forename: M
authors.initials: M
authors.lastname: Benkirane
authors.forename: C
authors.initials: C
authors.lastname: Van Lint
mesh_terms: D016475:3T3 Cells; D000107:Acetylation; D000123:Acetyltransferases / Q000378:metabolism*; D000818:Animals; D018797:Cell Cycle Proteins / Q000378:metabolism*; D056906:Cyclin T; D016213:Cyclins / Q000378:metabolism; D015967:Gene Expression Regulation, Viral / Q000235:genetics*; D015696:Gene Products, tat / Q000235:genetics / Q000378:metabolism*; D016325:HIV Long Terminal Repeat / Q000235:genetics; D015497:HIV-1 / Q000235:genetics*; D051548:Histone Acetyltransferases; D006801:Humans; D051379:Mice; D009154:Mutation; D042925:Positive Transcriptional Elongation Factor B; D011401:Promoter Regions, Genetic; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D012367:RNA, Viral / Q000378:metabolism; D016601:RNA-Binding Proteins / Q000378:metabolism; D029701:Saccharomyces cerevisiae Proteins; D014157:Transcription Factors; D014158:Transcription, Genetic; D014764:Viral Proteins / Q000378:metabolism; D050880:p300-CBP Transcription Factors; D054322:tat Gene Products, Human Immunodeficiency Virus; D000099224:p300-CBP-Associated Factor
chemical_list: D000123:Acetyltransferases; D018797:Cell Cycle Proteins; D056906:Cyclin T; D016213:Cyclins; D015696:Gene Products, tat; D051548:Histone Acetyltransferases; D042925:Positive Transcriptional Elongation Factor B; D017346:Protein Serine-Threonine Kinases; D012367:RNA, Viral; D016601:RNA-Binding Proteins; D029701:Saccharomyces cerevisiae Proteins; D014157:Transcription Factors; D014764:Viral Proteins; D050880:p300-CBP Transcription Factors; D054322:tat Gene Products, Human Immunodeficiency Virus; D000099224:p300-CBP-Associated Factor; C503684:CCNT1 protein, human; C503685:Ccnt1 protein, mouse